BIIB

Biogen Inc. · Healthcare · Drug Manufacturers - General
$218.50
-3.00 (-1.35%)
Mkt Cap: 32.28B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield7.9%
Dividend YieldN/A
Market Cap32.28B
Volume517.4K
Recent News
Why Is Biogen (BIIB) Up 6.5% Since Last Earnings Report?
zacks.com · 2026-08-28
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
zacks.com · 2026-08-27
Bank of Nova Scotia Buys Shares of 16,446 Biogen Inc. $BIIB
defenseworld.net · 2026-08-26
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
globenewswire.com · 2026-08-24
LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
prnewswire.com · 2026-08-24
Allworth Financial LP Takes $1.74 Million Position in Biogen Inc. $BIIB
defenseworld.net · 2026-08-22

Unlock the Full Deep Scan

9 AI agents analyze BIIB across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →